Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
NEOG: Neogen Corporation Stock Analysis | finqOS
Healthcare · Medical - Diagnostics & Research
The Story
NEOG
The Story
NEOG
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
-3.2% / yr
Operating margin
-2.5%
ROIC
-0.7%
Financially safe
Stretched
Debt / equity
0.38×
Interest coverage
-0.7×
Current ratio
3.82×
Neogen Corporation
NEOG
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Neogen Corporation
NEOG
NASDAQ
·
USD
·
Closed
$12.04
+4.42%
$12.04
+$0.51 (4.42%)
52W Range
99th
pctl
Volume
1.72×
avg
Mkt Cap
2.62B
USD
P/E
-362.7
TTM
Div Yield
–
ann
52W Range
99th
pctl
Volume
1.72×
avg
Market Cap
2.62B
USD
P/E Ratio
-362.7
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings